Dr Bruna Paulsen, PhD
VP of Manufacturing and Therapeutic Development, Gameto
VP of Manufacturing and Therapeutic Development, Gameto
Jan Jensen, PhD
CEO/CSO of Trailhead Biosystems
CEO/CSO of Trailhead Biosystems
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Anne E. Sheldrake, M.S.
StemBioSys
Todd J. Herron, Ph.D.
Frankel Cardiovascular Center, University of Michigan
StemBioSys
Todd J. Herron, Ph.D.
Frankel Cardiovascular Center, University of Michigan
Evelyn Chukwurah, Ph.D.
REPROCELL USA
Naiarah de Paz, M.Sc.
COO, Histocell
REPROCELL USA
Naiarah de Paz, M.Sc.
COO, Histocell
Dr Nikola Kolundzic
Study Director, REPROCELL Europe, UK
Study Director, REPROCELL Europe, UK
Dr Travis Block
Chief Technology Officer, StemBioSys
Chief Technology Officer, StemBioSys
David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Dr Amer Rana
Director of Biomedical Research Center, University of East Anglia, UK
Director of Biomedical Research Center, University of East Anglia, UK
Dr. Rachna Goyal
Manager, Preclinical Genomics, REPROCELL USA
Manager, Preclinical Genomics, REPROCELL USA
Masashi Iwakami
Nissan Chemical Corporation, Japan
Nissan Chemical Corporation, Japan
Dr David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Dr David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Dr. James Shoemaker
CSO, Lena Biosciences, USA
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Dr. James Shoemaker
CSO, Lena Biosciences, USA
Dr. Takuya Matsumoto
Institute for BioScience at Ajinomoto Co. Inc. Japan
Institute for BioScience at Ajinomoto Co. Inc. Japan
Prof. Anne Dickinson
Translational and Clinical Research Institute, Faculty of Medical Sciences, University of Newcastle upon Tyne, UK
Dr. Terri Lehman
Chief Technical Officer, REPROCELL Bioserve, USA
Translational and Clinical Research Institute, Faculty of Medical Sciences, University of Newcastle upon Tyne, UK
Dr. Terri Lehman
Chief Technical Officer, REPROCELL Bioserve, USA
Dr David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Dr. Hajime Onuki
Ajinomoto Co. Inc.
Ajinomoto Co. Inc.
Dr. Shaheda Ahmed
Scientific Manager, Alcyomics Ltd. UK
Scientific Manager, Alcyomics Ltd. UK
Dr. Daniel Haag
Head of Neuroscience and Co-founder of NeuCyte Inc. USA
Head of Neuroscience and Co-founder of NeuCyte Inc. USA
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Dr. Tsukasa Sugo
CEO and Founder of GenAhead Bio in Fujisawa, Japan
CEO and Founder of GenAhead Bio in Fujisawa, Japan
Dr. Jean Phillipe Richard
Stem Cell Director, REPROCELL USA
Stem Cell Director, REPROCELL USA
Dr. Karen McAuley
Clinical Alliances Manager, REPROCELL Europe
Graeme Macluskie
Director of Precision Medicine, REPROCELL Europe
Clinical Alliances Manager, REPROCELL Europe
Graeme Macluskie
Director of Precision Medicine, REPROCELL Europe